nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Cor pulmonale—Varenicline—nicotine dependence	0.046	0.0669	CcSEcCtD
Pregabalin—Multiple sclerosis—Varenicline—nicotine dependence	0.0385	0.0559	CcSEcCtD
Pregabalin—Bradyphrenia—Varenicline—nicotine dependence	0.0205	0.0298	CcSEcCtD
Pregabalin—Snoring—Varenicline—nicotine dependence	0.0191	0.0278	CcSEcCtD
Pregabalin—Thyroid disorder—Varenicline—nicotine dependence	0.0169	0.0245	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0129	0.0455	CbGpPWpGaD
Pregabalin—Mental retardation—Varenicline—nicotine dependence	0.0127	0.0185	CcSEcCtD
Pregabalin—Electrocardiogram ST segment depression—Varenicline—nicotine dependence	0.0122	0.0177	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0122	0.0431	CbGpPWpGaD
Pregabalin—Night blindness—Varenicline—nicotine dependence	0.0118	0.0171	CcSEcCtD
Pregabalin—Splenomegaly—Varenicline—nicotine dependence	0.00998	0.0145	CcSEcCtD
Pregabalin—Enterocolitis—Varenicline—nicotine dependence	0.00998	0.0145	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—CHRNB3—nicotine dependence	0.00985	0.0348	CbGpPWpGaD
Pregabalin—Abnormal faeces—Varenicline—nicotine dependence	0.00969	0.0141	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—CHRNA6—nicotine dependence	0.00933	0.033	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00929	0.0329	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00881	0.0312	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00881	0.0312	CbGpPWpGaD
Pregabalin—Facial paralysis—Varenicline—nicotine dependence	0.00871	0.0127	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00844	0.0299	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00785	0.0278	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00779	0.0275	CbGpPWpGaD
Pregabalin—Varicose vein—Varenicline—nicotine dependence	0.00744	0.0108	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00738	0.0261	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—CHRNB3—nicotine dependence	0.00712	0.0252	CbGpPWpGaD
Pregabalin—Coronary artery disease—Varenicline—nicotine dependence	0.00701	0.0102	CcSEcCtD
Pregabalin—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00675	0.00982	CcSEcCtD
Pregabalin—Withdrawal symptom—Varenicline—nicotine dependence	0.00675	0.00982	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—GABRA4—nicotine dependence	0.00675	0.0239	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—CHRNA6—nicotine dependence	0.00675	0.0239	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—CHRNB4—nicotine dependence	0.00647	0.0229	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0064	0.0226	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00637	0.0225	CbGpPWpGaD
Pregabalin—CACNA2D2—midbrain—nicotine dependence	0.00623	0.21	CbGeAlD
Pregabalin—Depressed mood—Varenicline—nicotine dependence	0.0062	0.00901	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00611	0.0216	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—CHRNA5—nicotine dependence	0.00601	0.0213	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—CHRNB3—nicotine dependence	0.00597	0.0211	CbGpPWpGaD
Pregabalin—Aphthous stomatitis—Varenicline—nicotine dependence	0.00591	0.00859	CcSEcCtD
Pregabalin—CACNA2D1—cardiovascular system—nicotine dependence	0.00574	0.193	CbGeAlD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00568	0.0201	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—CHRNA6—nicotine dependence	0.00566	0.02	CbGpPWpGaD
Pregabalin—Myositis—Varenicline—nicotine dependence	0.00565	0.00821	CcSEcCtD
Pregabalin—Peripheral vascular disorder—Varenicline—nicotine dependence	0.00565	0.00821	CcSEcCtD
Pregabalin—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00565	0.00821	CcSEcCtD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00563	0.0199	CbGpPWpGaD
Pregabalin—CACNA1A—brain—nicotine dependence	0.00556	0.187	CbGeAlD
Pregabalin—SLC1A1—brain—nicotine dependence	0.00543	0.183	CbGeAlD
Pregabalin—Suicide—Varenicline—nicotine dependence	0.00534	0.00777	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00534	0.0189	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00512	0.0181	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00512	0.0181	CbGpPWpGaD
Pregabalin—Balance disorder—Varenicline—nicotine dependence	0.00507	0.00737	CcSEcCtD
Pregabalin—Hostility—Varenicline—nicotine dependence	0.005	0.00728	CcSEcCtD
Pregabalin—Urine abnormality—Varenicline—nicotine dependence	0.005	0.00728	CcSEcCtD
Pregabalin—Osteoporosis—Varenicline—nicotine dependence	0.00494	0.00719	CcSEcCtD
Pregabalin—Sexual dysfunction—Varenicline—nicotine dependence	0.00494	0.00719	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—CHRNA3—nicotine dependence	0.0049	0.0173	CbGpPWpGaD
Pregabalin—Suicide attempt—Varenicline—nicotine dependence	0.00488	0.0071	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—GABRA4—nicotine dependence	0.00488	0.0173	CbGpPWpGaD
Pregabalin—Gastric ulcer—Varenicline—nicotine dependence	0.00477	0.00693	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00476	0.0168	CbGpPWpGaD
Pregabalin—Urine analysis abnormal—Varenicline—nicotine dependence	0.00471	0.00685	CcSEcCtD
Pregabalin—Completed suicide—Varenicline—nicotine dependence	0.00471	0.00685	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—CHRNB4—nicotine dependence	0.00468	0.0165	CbGpPWpGaD
Pregabalin—Platelet count decreased—Varenicline—nicotine dependence	0.00466	0.00677	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00463	0.0164	CbGpPWpGaD
Pregabalin—Libido increased—Varenicline—nicotine dependence	0.00455	0.00662	CcSEcCtD
Pregabalin—Vaginal discharge—Varenicline—nicotine dependence	0.00455	0.00662	CcSEcCtD
Pregabalin—Psoriasis—Varenicline—nicotine dependence	0.00441	0.00641	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—CHRNA5—nicotine dependence	0.00435	0.0154	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—CHRNB2—nicotine dependence	0.00432	0.0153	CbGpPWpGaD
Pregabalin—Parosmia—Varenicline—nicotine dependence	0.00427	0.00621	CcSEcCtD
Pregabalin—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00423	0.00615	CcSEcCtD
Pregabalin—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0041	0.00597	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—GABRA4—nicotine dependence	0.00409	0.0145	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00407	0.0144	CbGpPWpGaD
Pregabalin—Paranoia—Varenicline—nicotine dependence	0.00406	0.00591	CcSEcCtD
Pregabalin—Laryngeal pain—Varenicline—nicotine dependence	0.00406	0.00591	CcSEcCtD
Pregabalin—Menstrual disorder—Varenicline—nicotine dependence	0.00406	0.00591	CcSEcCtD
Pregabalin—Intestinal obstruction—Varenicline—nicotine dependence	0.00406	0.00591	CcSEcCtD
Pregabalin—Haematemesis—Varenicline—nicotine dependence	0.00399	0.0058	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—CHRNB4—nicotine dependence	0.00392	0.0139	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—CHRNA4—nicotine dependence	0.00392	0.0139	CbGpPWpGaD
Pregabalin—CACNA2D2—brain—nicotine dependence	0.00392	0.132	CbGeAlD
Pregabalin—Thrombosis—Varenicline—nicotine dependence	0.00391	0.00569	CcSEcCtD
Pregabalin—Delusion—Varenicline—nicotine dependence	0.00391	0.00569	CcSEcCtD
Pregabalin—Nystagmus—Varenicline—nicotine dependence	0.00388	0.00564	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00388	0.0137	CbGpPWpGaD
Pregabalin—Hyperlipidaemia—Varenicline—nicotine dependence	0.00384	0.00559	CcSEcCtD
Pregabalin—Mania—Varenicline—nicotine dependence	0.00381	0.00554	CcSEcCtD
Pregabalin—Menorrhagia—Varenicline—nicotine dependence	0.00374	0.00544	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.0037	0.0131	CbGpPWpGaD
Pregabalin—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00368	0.00535	CcSEcCtD
Pregabalin—Scotoma—Varenicline—nicotine dependence	0.00365	0.0053	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—CHRNA5—nicotine dependence	0.00364	0.0129	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00363	0.0128	CbGpPWpGaD
Pregabalin—Fungal infection—Varenicline—nicotine dependence	0.00359	0.00522	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—CHRNA3—nicotine dependence	0.00355	0.0125	CbGpPWpGaD
Pregabalin—Gingivitis—Varenicline—nicotine dependence	0.00353	0.00513	CcSEcCtD
Pregabalin—Mydriasis—Varenicline—nicotine dependence	0.00347	0.00505	CcSEcCtD
Pregabalin—Nephrolithiasis—Varenicline—nicotine dependence	0.00345	0.00501	CcSEcCtD
Pregabalin—Glycosuria—Varenicline—nicotine dependence	0.00342	0.00497	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00341	0.0121	CbGpPWpGaD
Pregabalin—Eye irritation—Varenicline—nicotine dependence	0.00324	0.00472	CcSEcCtD
Pregabalin—Disturbance in attention—Varenicline—nicotine dependence	0.0032	0.00465	CcSEcCtD
Pregabalin—Aggression—Varenicline—nicotine dependence	0.00315	0.00458	CcSEcCtD
Pregabalin—Chest discomfort—Varenicline—nicotine dependence	0.00313	0.00455	CcSEcCtD
Pregabalin—Accidental injury—Varenicline—nicotine dependence	0.00313	0.00455	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—CHRNB2—nicotine dependence	0.00312	0.011	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.0031	0.011	CbGpPWpGaD
Pregabalin—Viral infection—Varenicline—nicotine dependence	0.00307	0.00446	CcSEcCtD
Pregabalin—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00307	0.00446	CcSEcCtD
Pregabalin—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00307	0.00446	CcSEcCtD
Pregabalin—Thinking abnormal—Varenicline—nicotine dependence	0.00303	0.0044	CcSEcCtD
Pregabalin—Lacrimation increased—Varenicline—nicotine dependence	0.00301	0.00437	CcSEcCtD
Pregabalin—Nocturia—Varenicline—nicotine dependence	0.00299	0.00434	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—CHRNA3—nicotine dependence	0.00297	0.0105	CbGpPWpGaD
Pregabalin—Leukocytosis—Varenicline—nicotine dependence	0.00295	0.00429	CcSEcCtD
Pregabalin—Dysarthria—Varenicline—nicotine dependence	0.00293	0.00426	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—CHRNA4—nicotine dependence	0.00283	0.01	CbGpPWpGaD
Pregabalin—Coordination abnormal—Varenicline—nicotine dependence	0.00282	0.0041	CcSEcCtD
Pregabalin—CACNA2D1—brain—nicotine dependence	0.00282	0.0948	CbGeAlD
Pregabalin—Pulmonary embolism—Varenicline—nicotine dependence	0.00277	0.00403	CcSEcCtD
Pregabalin—Abnormal dreams—Varenicline—nicotine dependence	0.00274	0.00398	CcSEcCtD
Pregabalin—Hyperkalaemia—Varenicline—nicotine dependence	0.00272	0.00396	CcSEcCtD
Pregabalin—Eructation—Varenicline—nicotine dependence	0.00272	0.00396	CcSEcCtD
Pregabalin—Salivary hypersecretion—Varenicline—nicotine dependence	0.00269	0.00391	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—CHRNB2—nicotine dependence	0.00262	0.00925	CbGpPWpGaD
Pregabalin—Photophobia—Varenicline—nicotine dependence	0.0026	0.00378	CcSEcCtD
Pregabalin—Dry eye—Varenicline—nicotine dependence	0.00256	0.00372	CcSEcCtD
Pregabalin—Oesophagitis—Varenicline—nicotine dependence	0.00253	0.00368	CcSEcCtD
Pregabalin—Urine output increased—Varenicline—nicotine dependence	0.0025	0.00364	CcSEcCtD
Pregabalin—Mouth ulceration—Varenicline—nicotine dependence	0.0025	0.00364	CcSEcCtD
Pregabalin—Hypertonia—Varenicline—nicotine dependence	0.00243	0.00353	CcSEcCtD
Pregabalin—Mental disability—Varenicline—nicotine dependence	0.0024	0.0035	CcSEcCtD
Pregabalin—Euphoric mood—Varenicline—nicotine dependence	0.00238	0.00346	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—CHRNA4—nicotine dependence	0.00237	0.0084	CbGpPWpGaD
Pregabalin—Lymphadenopathy—Varenicline—nicotine dependence	0.00236	0.00343	CcSEcCtD
Pregabalin—Sleep disorder—Varenicline—nicotine dependence	0.00232	0.00338	CcSEcCtD
Pregabalin—Diabetes mellitus—Varenicline—nicotine dependence	0.00231	0.00336	CcSEcCtD
Pregabalin—Polyuria—Varenicline—nicotine dependence	0.00229	0.00333	CcSEcCtD
Pregabalin—Deafness—Varenicline—nicotine dependence	0.00225	0.00327	CcSEcCtD
Pregabalin—Disorientation—Varenicline—nicotine dependence	0.00225	0.00327	CcSEcCtD
Pregabalin—Eczema—Varenicline—nicotine dependence	0.00224	0.00325	CcSEcCtD
Pregabalin—Eye pain—Varenicline—nicotine dependence	0.00223	0.00324	CcSEcCtD
Pregabalin—Injury—Varenicline—nicotine dependence	0.00219	0.00318	CcSEcCtD
Pregabalin—Renal failure acute—Varenicline—nicotine dependence	0.00218	0.00317	CcSEcCtD
Pregabalin—Libido decreased—Varenicline—nicotine dependence	0.00217	0.00315	CcSEcCtD
Pregabalin—Hot flush—Varenicline—nicotine dependence	0.00215	0.00313	CcSEcCtD
Pregabalin—Increased appetite—Varenicline—nicotine dependence	0.00214	0.00311	CcSEcCtD
Pregabalin—Amnesia—Varenicline—nicotine dependence	0.00214	0.00311	CcSEcCtD
Pregabalin—Menopausal symptoms—Varenicline—nicotine dependence	0.00213	0.0031	CcSEcCtD
Pregabalin—Atrial fibrillation—Varenicline—nicotine dependence	0.00212	0.00309	CcSEcCtD
Pregabalin—Visual disturbance—Varenicline—nicotine dependence	0.00212	0.00309	CcSEcCtD
Pregabalin—Thirst—Varenicline—nicotine dependence	0.00211	0.00307	CcSEcCtD
Pregabalin—Arthritis—Varenicline—nicotine dependence	0.00207	0.00301	CcSEcCtD
Pregabalin—Hypoglycaemia—Varenicline—nicotine dependence	0.00206	0.003	CcSEcCtD
Pregabalin—Lethargy—Varenicline—nicotine dependence	0.00205	0.00298	CcSEcCtD
Pregabalin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00205	0.00298	CcSEcCtD
Pregabalin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00201	0.00292	CcSEcCtD
Pregabalin—Osteoarthritis—Varenicline—nicotine dependence	0.00201	0.00292	CcSEcCtD
Pregabalin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.002	0.0029	CcSEcCtD
Pregabalin—Affect lability—Varenicline—nicotine dependence	0.00198	0.00288	CcSEcCtD
Pregabalin—Migraine—Varenicline—nicotine dependence	0.00198	0.00288	CcSEcCtD
Pregabalin—Psychotic disorder—Varenicline—nicotine dependence	0.00196	0.00286	CcSEcCtD
Pregabalin—Irritability—Varenicline—nicotine dependence	0.00192	0.00279	CcSEcCtD
Pregabalin—Urinary retention—Varenicline—nicotine dependence	0.00191	0.00278	CcSEcCtD
Pregabalin—Mood swings—Varenicline—nicotine dependence	0.00191	0.00277	CcSEcCtD
Pregabalin—Liver function test abnormal—Varenicline—nicotine dependence	0.00186	0.0027	CcSEcCtD
Pregabalin—Dry skin—Varenicline—nicotine dependence	0.00184	0.00268	CcSEcCtD
Pregabalin—Hypokalaemia—Varenicline—nicotine dependence	0.00183	0.00266	CcSEcCtD
Pregabalin—Breast disorder—Varenicline—nicotine dependence	0.00182	0.00264	CcSEcCtD
Pregabalin—Cramp muscle—Varenicline—nicotine dependence	0.00181	0.00263	CcSEcCtD
Pregabalin—Nasopharyngitis—Varenicline—nicotine dependence	0.0018	0.00262	CcSEcCtD
Pregabalin—Gastritis—Varenicline—nicotine dependence	0.00178	0.00259	CcSEcCtD
Pregabalin—Abdominal distension—Varenicline—nicotine dependence	0.00175	0.00254	CcSEcCtD
Pregabalin—Asthma—Varenicline—nicotine dependence	0.00174	0.00253	CcSEcCtD
Pregabalin—Dysphagia—Varenicline—nicotine dependence	0.00174	0.00253	CcSEcCtD
Pregabalin—Angina pectoris—Varenicline—nicotine dependence	0.00169	0.00246	CcSEcCtD
Pregabalin—Bronchitis—Varenicline—nicotine dependence	0.00167	0.00243	CcSEcCtD
Pregabalin—Pollakiuria—Varenicline—nicotine dependence	0.00161	0.00233	CcSEcCtD
Pregabalin—Erectile dysfunction—Varenicline—nicotine dependence	0.0016	0.00233	CcSEcCtD
Pregabalin—Photosensitivity reaction—Varenicline—nicotine dependence	0.00159	0.00231	CcSEcCtD
Pregabalin—Weight increased—Varenicline—nicotine dependence	0.00158	0.0023	CcSEcCtD
Pregabalin—Hyperglycaemia—Varenicline—nicotine dependence	0.00157	0.00228	CcSEcCtD
Pregabalin—Infestation—Varenicline—nicotine dependence	0.00155	0.00225	CcSEcCtD
Pregabalin—Infestation NOS—Varenicline—nicotine dependence	0.00155	0.00225	CcSEcCtD
Pregabalin—Depression—Varenicline—nicotine dependence	0.00155	0.00225	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00154	0.00223	CcSEcCtD
Pregabalin—Acute coronary syndrome—Varenicline—nicotine dependence	0.00153	0.00222	CcSEcCtD
Pregabalin—Myocardial infarction—Varenicline—nicotine dependence	0.00152	0.00221	CcSEcCtD
Pregabalin—Stomatitis—Varenicline—nicotine dependence	0.00151	0.0022	CcSEcCtD
Pregabalin—Conjunctivitis—Varenicline—nicotine dependence	0.00151	0.00219	CcSEcCtD
Pregabalin—Epistaxis—Varenicline—nicotine dependence	0.00146	0.00213	CcSEcCtD
Pregabalin—Sinusitis—Varenicline—nicotine dependence	0.00145	0.00211	CcSEcCtD
Pregabalin—Bradycardia—Varenicline—nicotine dependence	0.00142	0.00206	CcSEcCtD
Pregabalin—Hallucination—Varenicline—nicotine dependence	0.00138	0.00201	CcSEcCtD
Pregabalin—Hypoaesthesia—Varenicline—nicotine dependence	0.00138	0.00201	CcSEcCtD
Pregabalin—Urinary tract disorder—Varenicline—nicotine dependence	0.00137	0.002	CcSEcCtD
Pregabalin—Oedema peripheral—Varenicline—nicotine dependence	0.00137	0.00199	CcSEcCtD
Pregabalin—Connective tissue disorder—Varenicline—nicotine dependence	0.00137	0.00199	CcSEcCtD
Pregabalin—Urethral disorder—Varenicline—nicotine dependence	0.00136	0.00198	CcSEcCtD
Pregabalin—Visual impairment—Varenicline—nicotine dependence	0.00134	0.00195	CcSEcCtD
Pregabalin—Erythema multiforme—Varenicline—nicotine dependence	0.00132	0.00191	CcSEcCtD
Pregabalin—Eye disorder—Varenicline—nicotine dependence	0.0013	0.00189	CcSEcCtD
Pregabalin—Tinnitus—Varenicline—nicotine dependence	0.0013	0.00189	CcSEcCtD
Pregabalin—Cardiac disorder—Varenicline—nicotine dependence	0.00129	0.00188	CcSEcCtD
Pregabalin—Angiopathy—Varenicline—nicotine dependence	0.00126	0.00184	CcSEcCtD
Pregabalin—Immune system disorder—Varenicline—nicotine dependence	0.00126	0.00183	CcSEcCtD
Pregabalin—Mediastinal disorder—Varenicline—nicotine dependence	0.00125	0.00182	CcSEcCtD
Pregabalin—Chills—Varenicline—nicotine dependence	0.00125	0.00182	CcSEcCtD
Pregabalin—Arrhythmia—Varenicline—nicotine dependence	0.00124	0.00181	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—CYP2A7—nicotine dependence	0.00123	0.00435	CbGpPWpGaD
Pregabalin—Mental disorder—Varenicline—nicotine dependence	0.00122	0.00177	CcSEcCtD
Pregabalin—Malnutrition—Varenicline—nicotine dependence	0.00121	0.00176	CcSEcCtD
Pregabalin—Flatulence—Varenicline—nicotine dependence	0.00119	0.00174	CcSEcCtD
Pregabalin—Dysgeusia—Varenicline—nicotine dependence	0.00119	0.00172	CcSEcCtD
Pregabalin—Back pain—Varenicline—nicotine dependence	0.00117	0.0017	CcSEcCtD
Pregabalin—Muscle spasms—Varenicline—nicotine dependence	0.00116	0.00169	CcSEcCtD
Pregabalin—Vision blurred—Varenicline—nicotine dependence	0.00114	0.00166	CcSEcCtD
Pregabalin—Tremor—Varenicline—nicotine dependence	0.00113	0.00165	CcSEcCtD
Pregabalin—Ill-defined disorder—Varenicline—nicotine dependence	0.00112	0.00163	CcSEcCtD
Pregabalin—Anaemia—Varenicline—nicotine dependence	0.00112	0.00163	CcSEcCtD
Pregabalin—Agitation—Varenicline—nicotine dependence	0.00111	0.00162	CcSEcCtD
Pregabalin—Angioedema—Varenicline—nicotine dependence	0.00111	0.00161	CcSEcCtD
Pregabalin—Malaise—Varenicline—nicotine dependence	0.00109	0.00159	CcSEcCtD
Pregabalin—Vertigo—Varenicline—nicotine dependence	0.00109	0.00158	CcSEcCtD
Pregabalin—Syncope—Varenicline—nicotine dependence	0.00109	0.00158	CcSEcCtD
Pregabalin—Palpitations—Varenicline—nicotine dependence	0.00107	0.00156	CcSEcCtD
Pregabalin—Loss of consciousness—Varenicline—nicotine dependence	0.00106	0.00155	CcSEcCtD
Pregabalin—Cough—Varenicline—nicotine dependence	0.00106	0.00154	CcSEcCtD
Pregabalin—Convulsion—Varenicline—nicotine dependence	0.00105	0.00153	CcSEcCtD
Pregabalin—Hypertension—Varenicline—nicotine dependence	0.00105	0.00152	CcSEcCtD
Pregabalin—Arthralgia—Varenicline—nicotine dependence	0.00103	0.0015	CcSEcCtD
Pregabalin—Chest pain—Varenicline—nicotine dependence	0.00103	0.0015	CcSEcCtD
Pregabalin—Myalgia—Varenicline—nicotine dependence	0.00103	0.0015	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—CYP2A7—nicotine dependence	0.00103	0.00364	CbGpPWpGaD
Pregabalin—Anxiety—Varenicline—nicotine dependence	0.00103	0.00149	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00102	0.00149	CcSEcCtD
Pregabalin—Discomfort—Varenicline—nicotine dependence	0.00102	0.00148	CcSEcCtD
Pregabalin—Dry mouth—Varenicline—nicotine dependence	0.00101	0.00147	CcSEcCtD
Pregabalin—Oedema—Varenicline—nicotine dependence	0.000988	0.00144	CcSEcCtD
Pregabalin—Infection—Varenicline—nicotine dependence	0.000982	0.00143	CcSEcCtD
Pregabalin—Shock—Varenicline—nicotine dependence	0.000972	0.00141	CcSEcCtD
Pregabalin—Nervous system disorder—Varenicline—nicotine dependence	0.000969	0.00141	CcSEcCtD
Pregabalin—Thrombocytopenia—Varenicline—nicotine dependence	0.000968	0.00141	CcSEcCtD
Pregabalin—Tachycardia—Varenicline—nicotine dependence	0.000965	0.0014	CcSEcCtD
Pregabalin—Skin disorder—Varenicline—nicotine dependence	0.00096	0.0014	CcSEcCtD
Pregabalin—Hyperhidrosis—Varenicline—nicotine dependence	0.000955	0.00139	CcSEcCtD
Pregabalin—Anorexia—Varenicline—nicotine dependence	0.000942	0.00137	CcSEcCtD
Pregabalin—Hypotension—Varenicline—nicotine dependence	0.000924	0.00134	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0009	0.00131	CcSEcCtD
Pregabalin—Insomnia—Varenicline—nicotine dependence	0.000894	0.0013	CcSEcCtD
Pregabalin—Dyspnoea—Varenicline—nicotine dependence	0.000881	0.00128	CcSEcCtD
Pregabalin—Somnolence—Varenicline—nicotine dependence	0.000879	0.00128	CcSEcCtD
Pregabalin—Decreased appetite—Varenicline—nicotine dependence	0.000859	0.00125	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000853	0.00124	CcSEcCtD
Pregabalin—Fatigue—Varenicline—nicotine dependence	0.000852	0.00124	CcSEcCtD
Pregabalin—Pain—Varenicline—nicotine dependence	0.000845	0.00123	CcSEcCtD
Pregabalin—Constipation—Varenicline—nicotine dependence	0.000845	0.00123	CcSEcCtD
Pregabalin—Feeling abnormal—Varenicline—nicotine dependence	0.000814	0.00118	CcSEcCtD
Pregabalin—Gastrointestinal pain—Varenicline—nicotine dependence	0.000808	0.00118	CcSEcCtD
Pregabalin—Urticaria—Varenicline—nicotine dependence	0.000785	0.00114	CcSEcCtD
Pregabalin—Body temperature increased—Varenicline—nicotine dependence	0.000781	0.00114	CcSEcCtD
Pregabalin—Abdominal pain—Varenicline—nicotine dependence	0.000781	0.00114	CcSEcCtD
Pregabalin—Hypersensitivity—Varenicline—nicotine dependence	0.000728	0.00106	CcSEcCtD
Pregabalin—Asthenia—Varenicline—nicotine dependence	0.000709	0.00103	CcSEcCtD
Pregabalin—Pruritus—Varenicline—nicotine dependence	0.000699	0.00102	CcSEcCtD
Pregabalin—Diarrhoea—Varenicline—nicotine dependence	0.000676	0.000983	CcSEcCtD
Pregabalin—Dizziness—Varenicline—nicotine dependence	0.000654	0.00095	CcSEcCtD
Pregabalin—Vomiting—Varenicline—nicotine dependence	0.000628	0.000914	CcSEcCtD
Pregabalin—Rash—Varenicline—nicotine dependence	0.000623	0.000906	CcSEcCtD
Pregabalin—Dermatitis—Varenicline—nicotine dependence	0.000623	0.000905	CcSEcCtD
Pregabalin—Headache—Varenicline—nicotine dependence	0.000619	0.0009	CcSEcCtD
Pregabalin—Nausea—Varenicline—nicotine dependence	0.000587	0.000854	CcSEcCtD
